2-Pyrrolidone → 1-{5-Chloro-2-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}pyrrolidin-2-one

HRID 2411305Notes

Reaction equation

HRID 2411305 reaction equation
Br[C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[C:9]([N:11]1[CH2:16][CH2:15][N:14]([C:17]2[C:22]([CH3:23])=[CH:21][C:20]([CH3:24])=[CH:19][N:18]=2)[CH2:13][CH2:12]1)=[O:10].[NH:25]1[CH2:29][CH2:28][CH2:27][C:26]1=[O:30]>>[Cl:8][C:6]1[CH:5]=[CH:4][C:3]([C:9]([N:11]2[CH2:16][CH2:15][N:14]([C:17]3[C:22]([CH3:23])=[CH:21][C:20]([CH3:24])=[CH:19][N:18]=3)[CH2:13][CH2:12]2)=[O:10])=[C:2]([N:25]2[CH2:29][CH2:28][CH2:27][C:26]2=[O:30])[CH:7]=1

Participants

3

Procedure

Using (2-bromo-4-chlorophenyl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (1.57 g) described in Preparation Example 167 and pyrrolidin-2-one (327 mg) and by the reaction and treatment in the same manner as in Preparation Example 48, the title compound (720 mg) was obtained.

Sources & evidence

ORD record
ord-20b43f888f884c53a0063e65d8ced0ad
Source dataset
uspto-grants-2014_08
Patent number
US08816079B2

Reaction notes

Loading…